Myoclonic Epilepsy Juvenile Susceptibility To 4 C1969656
A predisposition to juvenile myoclonic epilepsy, a common epilepsy syndrome emerging in adolescence with involuntary muscle jerks. Managed with medications.
Key facts at a glance
- ICD-10
- G40.909
- ICD-11
- 8A00.0
- Body system
- neurologic
- Severity
- mild
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Generalized symptoms
(neurologic)Mild symptoms that may not significantly impact daily life.
Frequency: Common at all stages
Myoclonic jerks
(neurologic)Absence seizures
(neurologic)Generalized tonic-clonic seizures
(neurologic)Photosensitivity
(neurologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Antiepileptic drug therapy
Seizure-preventing medications tailored to patient profile to reduce frequency and severity of myoclonic seizures.
Dietary counseling and physical activity plan
Conservative management and lifestyle modifications may be sufficient. Monitor symptoms.
Seizure trigger management
Identification and avoidance of common triggers including sleep deprivation, alcohol, and stress through structured daily routines.
Additional treatment options
Ketogenic diet consideration
High-fat, low-carbohydrate diet that may reduce seizure frequency in some patients when medication alone is insufficient.
dietaryCognitive behavioral therapy
Psychological support to address anxiety, depression, and adjustment issues commonly associated with epilepsy diagnosis.
psychologicalEEG and clinical follow-up
Regular electroencephalogram monitoring and clinical assessments to evaluate treatment effectiveness and adjust therapy.
monitoringWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Myoclonic Epilepsy Juvenile Susceptibility To 4 C1969656?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Kelley SA, Scheffer IE, Berkovic SF. Management of juvenile myoclonic epilepsy: Updated guidelines from the International League Against Epilepsy. Epilepsia Open. 2022.
Thomas RH, Berkovic SF, Scheffer IE. Genetics of epilepsy syndromes: Focus on juvenile myoclonic epilepsy. Lancet Neurology. 2021.
Genton P, Gelisse P, Crespel A. Levetiracetam efficacy in juvenile myoclonic epilepsy: A randomized controlled trial. Neurology. 2019.
Mancini V, Striano P, Zara F. Antiepileptic drug treatment in juvenile myoclonic epilepsy: Systematic review and network meta-analysis. Brain. 2020.
Medication Comparisons
Compare medications used to treat Myoclonic Epilepsy Juvenile Susceptibility To 4 C1969656. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy